Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Materion Q3 sales rise 28% but miss estimates

Materion Q3 sales rise 28% but miss estimates

ReutersReuters2026/11/04 11:57


Overview

  • US advanced materials supplier's Q3 net sales rose 28% yr/yr but missed analyst expectations

  • Adjusted EPS for Q3 beat analyst expectations

  • Company raised full-year adjusted EPS outlook, citing record backlog and strong demand


Outlook

  • Materion raises full-year adjusted EPS guidance to $7.10-$7.40

  • Company expects higher Q4 sales driven by record backlog and strong demand

  • Materion cites record backlog and order momentum supporting 2026 outlook


Result Drivers

  • SEMICONDUCTOR SALES - Co said record quarterly semiconductor sales and growth in aerospace & defense and telecom & data center markets drove value-added sales

  • VOLUME AND PRICE/MIX - Higher sales volumes and improved price/mix contributed to margin expansion, per co

  • ORDER BACKLOG - Co said incoming orders and backlog reached all-time highs, supporting outlook


Company press release: ID:nBw7LQLjxa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Miss

$567.30 mln

$611.38 mln (5 Analysts)

Q3 Adjusted EPS

Beat

$1.93

$1.89 (6 Analysts)

Q3 Net Income

$38.30 mln

Q3 Adjusted EBITDA

Slight Miss*

$70.70 mln

$70.84 mln (5 Analysts)

Q3 Operating Profit

$50.40 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the diversified mining peer group is "buy"

  • Wall Street's median 12-month price target for Materion Corporation is $306.00, about 34.5% above its November 3 closing price of $227.43

  • The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 30 three months ago


Reuters Recommended Reads

  • Nov 3 - EnPro beats Q3 sales, profit estimates on semiconductor demand, outlook raised

  • Nov 2 - Israel's Tower Semi Q3 revenue growth of 33% tops estimates, sees faster Q4 growth

  • Nov 3 - Navitas Semiconductor Q3 revenue beats estimates on rising demand from AI data centers and grid infrastructure


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss